2023-08-14 16:18:48 ET
- Definitive Healthcare press release ( NASDAQ: DH ): Q2 Non-GAAP EPS of $0.08 beats by $0.02 .
- Revenue of $61M (+11.9% Y/Y) in-line.
-
Third Quarter 2023:
-
Revenue is expected to be in the range of $63.0 – $64.5 million, a 10-12% increase year over year.
-
Adjusted Operating Income is expected to be in the range of $16.0 – $17.0 million.
- Adjusted EBITDA is expected to be in the range of $17.5 – $18.5 million.
- Adjusted Net Income is expected to be $9.5 – $10.5 million.
- Adjusted Net Income Per Diluted Share is expected to be $0.05 – $0.07 per share on approximately 156.9 million weighted-average shares outstanding.
- Full Year 2023:
- Revenue is expected to be in the range of $249.0 – $255.0 million, up 12% – 15% from prior year.
- Adjusted Operating Income is expected to be in the range of $61.5 – $65.5 million.
- Adjusted EBITDA is expected to be in the range of $67.0 – $71.0 million.
- Adjusted Net Income is expected to be $30.0 – $34.0 million.
- Adjusted Net Income Per Diluted Share is expected to be $0.19 – $0.23 per share on approximately 155.4 million weighted-average shares outstanding.
For further details see:
Definitive Healthcare Non-GAAP EPS of $0.08 beats by $0.02, revenue of $61M in-line